EPA Region 

 III Philadelphia 



Use and Interpretation of 

 The Data in IRIS 



IV 



VI 



Atlanta 



Chicago 



Dallas 



IRIS Contacts 



Roy Smith 

 (215) 597-9857 

 FTS 597-9857 



Gayle Alston 

 (404) 347-4216 

 FTS 257-4216 



David Dolan 

 (312) 886-6195 

 FTS 886-6195 



Fred Reitman 

 (214) 655-2235 

 FTS 886-2235 



Jill Lyons 

 (214) 655-7208 

 FTS 255-7208 



Bob Fenemore 

 (913) 236-2970 

 FTS 255-2970 



Jim Baker 



(303) 293-1524 

 FTS 564-1524 



Arnold Den 

 (415) 974-0906 

 FTS 454-0906 



Dave Tetta 



(206) 442-2138 

 FTS 399-2138 



Dana Davoli 

 (206) 442-2135 

 FTS 399-2135 



10) When will (chemical name) be included in IRIS? When will the 

 reference dose for (chemical name) be added to IRIS? When will the 

 carcinogen assessment for (chemical name) be added to IRIS? 

 Call IRIS User Support at (513) 569-7254 or FTS 684-7254. 



VII 



VIII 



IX 



Kansas City 



Denver 



San Francisco 



Seattle 



Lindane; CAS No. 58-89-9 



Health risk assessment information on a chemical is included in IRIS 

 only after a comprehensive review of chronic toxicity data by work 

 groups composed of U.S. EPA scientists from several Program Offices. 

 The summaries presented in Sections I and II represent a consensus 



